ID   MEL-RC08
AC   CVCL_A012
DR   cancercelllines; CVCL_A012
DR   Cosmic; 1667648
DR   Wikidata; Q54905128
RX   PubMed=22529031;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=22529031).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22529031).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=22529031).
CC   Derived from site: Metastatic; Bone, periosteum, pericranium; UBERON=UBERON_0013687.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=22529031; DOI=10.1007/s13577-011-0027-y;
RA   Gil-Benso R., Monteagudo C., Cerda-Nicolas M., Callaghan R.C.,
RA   Pinto S., Martinez-Romero A., Pellin-Carcelen A., San-Miguel T.,
RA   Cigudosa J.C., Lopez-Gines C.;
RT   "Characterization of a new human melanoma cell line with CD133
RT   expression.";
RL   Hum. Cell 25:61-67(2012).
//